200 related articles for article (PubMed ID: 32689851)
1. The double-edged role of IL-22 in organ fibrosis.
Chen J; Lodi R; Zhang S; Su Z; Wu Y; Xia L
Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):392-399. PubMed ID: 32689851
[TBL] [Abstract][Full Text] [Related]
2. Matrix Stiffness: the Conductor of Organ Fibrosis.
Santos A; Lagares D
Curr Rheumatol Rep; 2018 Jan; 20(1):2. PubMed ID: 29349703
[TBL] [Abstract][Full Text] [Related]
3. The myofibroblast matrix: implications for tissue repair and fibrosis.
Klingberg F; Hinz B; White ES
J Pathol; 2013 Jan; 229(2):298-309. PubMed ID: 22996908
[TBL] [Abstract][Full Text] [Related]
4. Renal Inflammation and Fibrosis: A Double-edged Sword.
Black LM; Lever JM; Agarwal A
J Histochem Cytochem; 2019 Sep; 67(9):663-681. PubMed ID: 31116067
[TBL] [Abstract][Full Text] [Related]
5. Regulation of fibrotic changes by the synergistic effects of cytokines, dimensionality and matrix: Towards the development of an in vitro human dermal hypertrophic scar model.
Chawla S; Ghosh S
Acta Biomater; 2018 Mar; 69():131-145. PubMed ID: 29330036
[TBL] [Abstract][Full Text] [Related]
6. Human Fibrotic Diseases: Current Challenges in Fibrosis Research.
Rosenbloom J; Macarak E; Piera-Velazquez S; Jimenez SA
Methods Mol Biol; 2017; 1627():1-23. PubMed ID: 28836191
[TBL] [Abstract][Full Text] [Related]
7. Host responses in tissue repair and fibrosis.
Duffield JS; Lupher M; Thannickal VJ; Wynn TA
Annu Rev Pathol; 2013 Jan; 8():241-76. PubMed ID: 23092186
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronan's Role in Fibrosis: A Pathogenic Factor or a Passive Player?
Albeiroti S; Soroosh A; de la Motte CA
Biomed Res Int; 2015; 2015():790203. PubMed ID: 26583132
[TBL] [Abstract][Full Text] [Related]
9. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
10. Fibrostenotic Phenotype of Myofibroblasts in Crohn's Disease is Dependent on Tissue Stiffness and Reversed by LOX Inhibition.
de Bruyn JR; van den Brink GR; Steenkamer J; Buskens CJ; Bemelman WA; Meisner S; Muncan V; Te Velde AA; D'Haens GR; Wildenberg ME
J Crohns Colitis; 2018 Jun; 12(7):849-859. PubMed ID: 29672662
[TBL] [Abstract][Full Text] [Related]
11. Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease.
Kramann R; DiRocco DP; Humphreys BD
J Pathol; 2013 Nov; 231(3):273-89. PubMed ID: 24006178
[TBL] [Abstract][Full Text] [Related]
12. Resolution of organ fibrosis.
Jun JI; Lau LF
J Clin Invest; 2018 Jan; 128(1):97-107. PubMed ID: 29293097
[TBL] [Abstract][Full Text] [Related]
13. Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review).
Di Benedetto P; Ruscitti P; Liakouli V; Del Galdo F; Giacomelli R; Cipriani P
Mol Med Rep; 2019 Aug; 20(2):1488-1498. PubMed ID: 31257535
[TBL] [Abstract][Full Text] [Related]
14. Immune Mechanisms and Related Targets for the Treatment of Fibrosis in Various Organs.
Pinar AA; Samuel CS
Curr Mol Med; 2022; 22(3):240-249. PubMed ID: 35034593
[TBL] [Abstract][Full Text] [Related]
15. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets.
Ezhilarasan D; Sokal E; Najimi M
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):192-197. PubMed ID: 29709350
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of IL-18 reduces renal fibrosis after ischemia-reperfusion.
Liang H; Xu F; Zhang T; Huang J; Guan Q; Wang H; Huang Q
Biomed Pharmacother; 2018 Oct; 106():879-889. PubMed ID: 30119258
[TBL] [Abstract][Full Text] [Related]
17. Relaxin and extracellular matrix remodeling: Mechanisms and signaling pathways.
Ng HH; Shen M; Samuel CS; Schlossmann J; Bennett RG
Mol Cell Endocrinol; 2019 May; 487():59-65. PubMed ID: 30660699
[TBL] [Abstract][Full Text] [Related]
18. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic approaches to control tissue repair and fibrosis: Extracellular matrix as a game changer.
Walraven M; Hinz B
Matrix Biol; 2018 Oct; 71-72():205-224. PubMed ID: 29499355
[TBL] [Abstract][Full Text] [Related]
20. Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family.
Sziksz E; Pap D; Lippai R; Béres NJ; Fekete A; Szabó AJ; Vannay Á
Mediators Inflamm; 2015; 2015():764641. PubMed ID: 26199463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
